The Good: I saw a special on CNN last night that corroborated these facts. The Bad: Only 50% of Kenyan babies with HIV-infected mothers receive this drug. And, that percentage is much lower in other African countries.

Quoted: In tandem with these studies are those investigating the efficacy, and practicality, of the drug, nevirapine. Using this drug in a study involving pregnant HIV-infected women in Uganda, Laura Guay, an assistant professor of pathology and pediatrics at Johns Hopkins University School of Medicine in Baltimore, and colleagues achieved a 48 percent reduction in perinatal transmission rates, while holding the drug treatment costs to a mere $4.